EMEA-002431-PIP02-21 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Oncology
PIP number: P/0006/2022
Route(s) of administration: Oral use
Pharmaceutical form(s):
Age-appropriate oral liquid dosage form
Capsule (hard)
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Alecensa
alectinib
Carcinoma, Non-Small-Cell Lung
Date of authorisation:
Revision: 14
Last updated:
MedicineHumanAuthorised
EMEA-002431-PIP01-18 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Oncology
PIP number: P/0359/2018
Route(s) of administration: Oral use
Pharmaceutical form(s):
Capsule (hard)
Decision date:
Last updated:
Compliance check: ✖
PIPHuman